DK0549880T3 - N-(3-(2-(1H-Imidazol-1-yl)ethoxy)-phenyl)-4-(2-thienyl)-2-pyrimidinamin og farmakologisk acceptable salte - Google Patents

N-(3-(2-(1H-Imidazol-1-yl)ethoxy)-phenyl)-4-(2-thienyl)-2-pyrimidinamin og farmakologisk acceptable salte

Info

Publication number
DK0549880T3
DK0549880T3 DK92119890T DK92119890T DK0549880T3 DK 0549880 T3 DK0549880 T3 DK 0549880T3 DK 92119890 T DK92119890 T DK 92119890T DK 92119890 T DK92119890 T DK 92119890T DK 0549880 T3 DK0549880 T3 DK 0549880T3
Authority
DK
Denmark
Prior art keywords
pyrimidinamine
imidazol
thienyl
ethoxy
phenyl
Prior art date
Application number
DK92119890T
Other languages
Danish (da)
English (en)
Inventor
Rolf Paul
Lawrence W Torley
Robert Gerard Kelly
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DK0549880T3 publication Critical patent/DK0549880T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK92119890T 1991-12-31 1992-11-23 N-(3-(2-(1H-Imidazol-1-yl)ethoxy)-phenyl)-4-(2-thienyl)-2-pyrimidinamin og farmakologisk acceptable salte DK0549880T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/816,335 US5162328A (en) 1991-12-31 1991-12-31 N-[3-[2-(1H-imidazol-1-yl)ethoxy]phenyl]-4-(2-thienyl)-2-pyrimidinamine and pharmacologically acceptable salts

Publications (1)

Publication Number Publication Date
DK0549880T3 true DK0549880T3 (da) 1999-06-14

Family

ID=25220310

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92119890T DK0549880T3 (da) 1991-12-31 1992-11-23 N-(3-(2-(1H-Imidazol-1-yl)ethoxy)-phenyl)-4-(2-thienyl)-2-pyrimidinamin og farmakologisk acceptable salte

Country Status (16)

Country Link
US (1) US5162328A (fr)
EP (1) EP0549880B1 (fr)
JP (1) JPH05271227A (fr)
KR (1) KR930012761A (fr)
AT (1) ATE171178T1 (fr)
AU (1) AU651539B2 (fr)
CA (1) CA2086357A1 (fr)
DE (1) DE69227015T2 (fr)
DK (1) DK0549880T3 (fr)
ES (1) ES2121809T3 (fr)
FI (1) FI925951A (fr)
HU (1) HUT66943A (fr)
NO (1) NO301476B1 (fr)
NZ (1) NZ245513A (fr)
SG (1) SG47556A1 (fr)
ZA (1) ZA9210120B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7803806B2 (en) * 2005-11-03 2010-09-28 Sgx Pharmaceuticals, Inc. Pyrimidinyl-thiophene kinase modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4788195A (en) * 1986-01-13 1988-11-29 American Cyanamid Company 4,5,6-substituted-N-(substituted-phenyl)-2-pyrimidinamines
SG47583A1 (en) * 1986-01-13 1998-04-17 American Cyanamid Co 4,5,6-Substituted-n- (substituted-phenyl) -2- pyrimidinamines

Also Published As

Publication number Publication date
DE69227015T2 (de) 1999-03-25
AU3046292A (en) 1993-07-08
ES2121809T3 (es) 1998-12-16
NO301476B1 (no) 1997-11-03
HU9204172D0 (en) 1993-04-28
NO924760D0 (no) 1992-12-09
NZ245513A (en) 1994-07-26
FI925951A0 (fi) 1992-12-30
SG47556A1 (en) 1998-04-17
HUT66943A (en) 1995-01-30
JPH05271227A (ja) 1993-10-19
KR930012761A (ko) 1993-07-21
EP0549880A1 (fr) 1993-07-07
CA2086357A1 (fr) 1993-07-01
ATE171178T1 (de) 1998-10-15
ZA9210120B (en) 1994-04-12
US5162328A (en) 1992-11-10
DE69227015D1 (de) 1998-10-22
EP0549880B1 (fr) 1998-09-16
AU651539B2 (en) 1994-07-21
FI925951A (fi) 1993-07-01
NO924760L (no) 1993-07-01

Similar Documents

Publication Publication Date Title
NO20052755D0 (no) Krystallmodifikasjon av et N-fenyl-2-pyrimidinaminderivat, fremgangsmate for dens fremstilling og dens anvendelse.
NO933093D0 (no) Monohydrat av 5-(2-(4-(1,2-benzisotiazol-3-yl)-1-piperazinyl)-etyl)-6-klor-1,3-dihydro-2h-indol-2-on hydroklorid
DK0957099T3 (da) Heterocykliske carboxamider
UY26480A1 (es) Inhibidores de n - (5 - ( 5 - alquil - 2 - oxazolil) metil ) tio) - 2 - tiazolil) - carboxamida de cinasas dependientes de ciclina
KR920021522A (ko) 피페라진 유도체
HUP9902808A2 (hu) 5-(2-(4-(1,2-Benzizotiazol-3-il)-1-piperazinil)-etil)-6-klór-1,3-dihidro-2-(1H)-indol-2-on (ziprazidon) mezilát-trihidrát sói, a vegyületek előállítása és dopamin D2 antagonistaként történő alkalmazása
DE60223245D1 (de) Thiazol- und oxazolderivate, die sich für die behandlung von herzkreislauferkrankungen und ähnlichen erkrankungen eignen
ATE321556T1 (de) Behandlung gastrointestinaler stroma-tumoren
NO964950L (no) Krystallinsk hydroklorid av (R)-(-)-2-{N-£4-(1,1-dioksido-3-okso-2,3-dihydro-benziso-tiazol-2-yl)-butyl|-aminometyl}-kroman
EA199800912A1 (ru) Дигидратная соль мезилата 5-(2-(4-(1,2-бензизотиазол-3-ил)-1-пиперазинил)этил)-6-хлор-1,3-дигидро-2(1н)-индол-2-она, фармацевтическая композиция и способ лечения психотического расстройства
DK0669920T3 (da) Substituerede 3-(aminoalkylamino)-1,2-benzisoxazoler og beslægtede forbindelser
TR200001872A3 (tr) 4-[5-(4-Metilfenil-3-(triflorometil)-1H-pirazol-1-il] benzensulfonamit' in yeni kristal biçimi "Biçim I" ve bu ürünün üretilmesine iliskin yöntem.
NZ528997A (en) Sulfonamides
DE69104314T2 (de) Verwendung von 1-[3-(Dimethylamino)propyl]-1-phenylphthalenen zur Behandlung zerebrovaskulärer Störungen.
DE602004023185D1 (de) Phenylsulfonderivate und deren verwendung bei der behandlung von zns-erkrankungen
PT790236E (pt) Pro-farmacos de 5-(2-(4-(1,2-benzisotiazol-3-il)-1-piperazinil)-etil-6-cloro-1,3-di-hidro-2h-indol-2-ona
DK0549880T3 (da) N-(3-(2-(1H-Imidazol-1-yl)ethoxy)-phenyl)-4-(2-thienyl)-2-pyrimidinamin og farmakologisk acceptable salte
BR0201569A (pt) 4-(2-piridil) piperizinas possuindo uma atividade agonista do receptor 5ht7
HUP0102836A2 (hu) Oxazolidinonok alkalmazása a szem fertőzéses megbetegedéseinek kezelésére alkalmas gyógyászati készítmények előállítására
NO964269D0 (no) 2,3-dihydroksypropyl 2-(1-oksoalkyl)amino-2-deoksogluco-pyranosider, deres fremstilling og anvendelse
HUP0303185A2 (hu) GlyT-1 inhibitorok, eljárás előállításukra, és eljárásban használt köztitermékek és a vegyületeket tartalmazó gyógyászati készítmények
FI972528A0 (fi) Menetelmä N-(4-(5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yyli-metyyli)-3-metoksibentsoyyli)-2-metyylibentseenisulfonamidin fysikaalisen muodon valmistamiseksi